Cost-effectiveness analysis of lanthanum carbonate versus sevelamer hydrochloride in the treatment of hyperphosphatemia in patients with end-stage renal disease in Spain

  1. González-Parra, E.
  2. Gros, B.
  3. Galán, A.
  4. Herrero, J.A.
  5. Oyagüez, I.
  6. Keith, M.
  7. Casado, M.Á.
Aldizkaria:
Pharmacoeconomics - Spanish Research Articles

ISSN: 1989-5453 1695-405X

Argitalpen urtea: 2015

Alea: 12

Zenbakia: 1

Orrialdeak: 11-22

Mota: Artikulua

DOI: 10.1007/S40277-014-0031-1 GOOGLE SCHOLAR